This company has been marked as potentially delisted and may not be actively trading. NASDAQ:EXAC Exactech (EXAC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Exactech Stock (NASDAQ:EXAC) 30 days 90 days 365 days Advanced Chart Get Exactech alerts:Sign Up Key Stats Today's Range$49.25▼$49.3050-Day Range N/A52-Week Range$23.75▼$50.95Volume255,640 shsAverage Volume182,742 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft. Read More Receive EXAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exactech and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAC Stock News HeadlinesGators Unveil Loaded 2025-26 Non-Conference Basketball SlateJuly 2, 2025 | msn.comExactech Showcases Groundbreaking Research in AI and Personalized Surgical TechnologiesJuly 1, 2025 | finance.yahoo.comTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. July 7 at 2:00 AM | Paradigm Press (Ad)First Patient Treated with the Alteon® Short Tapered Wedge Total Hip ReplacementJune 23, 2025 | finance.yahoo.comImplant Maker Exactech Preps Bankruptcy Plan Without TPG DealJune 2, 2025 | wsj.comExactech Launches Next-Generation Shoulder Planning App with Advanced Surgical FeaturesMay 27, 2025 | finance.yahoo.comTop college volleyball transfer with Wisconsin ties lands with Big Ten rival in portalMay 7, 2025 | msn.comTop college volleyball transfer with Wisconsin ties lands with Big Ten rival in portalMay 7, 2025 | msn.comSee More Headlines EXAC Stock Analysis - Frequently Asked Questions How were Exactech's earnings last quarter? Exactech Inc (NASDAQ:EXAC) released its earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.03. The medical equipment provider earned $61.40 million during the quarter, compared to the consensus estimate of $61.78 million. What other stocks do shareholders of Exactech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Exactech investors own include Immersion (IMMR), Verizon Communications (VZ), Bristol Myers Squibb (BMY), Johnson & Johnson (JNJ), Meta Platforms (META), Riot Platforms (RIOT) and Allergan (AGN). Company Calendar Last Earnings10/30/2017Today7/07/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:EXAC CIK913165 Webwww.exac.com Phone+1-352-3771140FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:EXAC) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exactech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Exactech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.